ArticleESMO open2020
Call for ensuring cancer care continuity during COVID-19 pandemic.
Abstract readLetterComment
In one paragraph
Article in ESMO open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis.JAMA network open · 2022Pooled it
- Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis.Critical reviews in oncology/hematology · 2021Pooled it
- Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies.European journal of cancer (Oxford, England : 1990) · 2020Pooled it
- COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon.Infectious agents and cancer · 2025Review
- Cancer nurses' experience during the COVID-19 pandemic: Multicenter mixed-methods study on coping and resilience strategies.BMC nursing · 2024Article
- Article
- The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy.Biology · 2023Article
- SARS-CoV-2 infection as a potential risk factor for the development of cancer.Frontiers in molecular biosciences · 2023Review
- Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the COVID-19 Pandemic.The oncologist · 2022Article
- Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy.Cancers · 2022Article
- What Has Changed During the COVID-19 Pandemic? - The Effect on an Academic Breast Department in Portugal.European journal of breast health · 2022Article
- The Novel Coronavirus (COVID-19) Pandemic and the Response in Low-to-Middle Income Countries.Current breast cancer reports · 2021Review
- The Impact of COVID-19 on Cancer.Infection and drug resistance · 2021Review
- Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.International journal of cancer · 2020Article
- Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic.BMC cancer · 2020Article
- Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic.Future oncology (London, England) · 2020Review
- COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study.ESMO open · 2020Observational
- Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?ESMO open · 2020Article
- Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak.European journal of clinical investigation · 2020Article
- Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin ice.Radiation oncology (London, England) · 2020Article
Corrections and comments
- Comment on
Authors and funding
11 authors.
Marco TagliamentoDepartment of Internal Medicine and Medical Specialties (Di.M.I.), School of Medicine, University of Genoa, Genoa, Italy; Department of Medical Oncology, U.O.C. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: tagliamento.marco@gmail.com.
Matteo LambertiniDepartment of Internal Medicine and Medical Specialties (Di.M.I.), School of Medicine, University of Genoa, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Carlo GenovaDepartment of Medical Oncology, U.O.C. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Emanuela BarisioneInterventional Pneumology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Andrea De MariaDepartment of Health Sciences, University of Genoa, Genoa, Italy; Infectious Diseases Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Marco GrossoInterventional Pneumology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Francesca PoggioDepartment of Medical Oncology, U.O.C. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Stefano VaggeDepartment of Radiation Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Francesco BoccardoDepartment of Internal Medicine and Medical Specialties (Di.M.I.), School of Medicine, University of Genoa, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Paolo PronzatoDepartment of Medical Oncology, U.O.C. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Lucia Del MastroDepartment of Internal Medicine and Medical Specialties (Di.M.I.), School of Medicine, University of Genoa, Genoa, Italy; Department of Medical Oncology, U.O.C. Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Continuity of Patient CarePandemicsBetacoronavirusChinaCoronavirus InfectionsCOVID-19HumansPneumonia, ViralRetrospective StudiesSARS-CoV-2cancerCOVID-19SARS-CoV-2treatment
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.